NASDAQ: ANAB - AnaptysBio, Inc.

Yield per half year: -51.5%
Sector: Healthcare

Share chart AnaptysBio, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

AnaptysBio, Inc., биотехнологическая компания на клинической стадии, занимается разработкой терапевтических продуктов-кандидатов для лечения воспалений и иммуноонкологических показаний. Продукция компании включает этокимаб, анти-интерлейкин (IL) -33 программу для лечения атопического дерматита, эозинофильной астмы и хронического риносинусита с полипами носа; ANB019, рецептор против IL-36 для генерализованного пустулезного псориаза и ладонно-подошвенного пустулезного псориаза; и противовоспалительные модуляторы контрольных точек при воспалительных заболеваниях.

more details
Он также разрабатывает иммуноонкологические продукты, в том числе TSR-042: анти-PD-1, TSR-022: анти-TIM-3, TSR-033: анти-LAG-3 и TSR-075: анти-PD-1. / LAG-3 биспецифический; и CC-90006: агонист против PD-1 от псориаза, а также другие продукты от воспаления. AnaptysBio, Inc. имеет иммуноонкологические партнерские отношения с TESARO, Inc. и TESARO Development, Ltd .; сотрудничество с Celgene Corporation; и соглашение о сотрудничестве в области иммуноонкологии с GlaxoSmithKline plc. Компания ранее была известна как Anaptys Biosciences, Inc. и сменила название на AnaptysBio, Inc. в июле 2006 года. AnaptysBio, Inc. была основана в 2005 году, ее штаб-квартира находится в Сан-Диего, Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2017-01-26
ISIN US0327241065
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.anaptysbio.com
Цена ао 14.21
Change price per day: +1.32% (16.63)
Change price per week: +6.31% (15.85)
Change price per month: +21.31% (13.89)
Change price per 3 month: -47.39% (32.03)
Change price per half year: -51.5% (34.74)
Change price per year: -28.63% (23.61)
Change price per 3 year: -44.19% (30.19)
Change price per 5 year: -12.42% (19.24)
Change price per 10 year: 0% (16.85)
Change price per year to date: +22.63% (13.74)
All parameters

Underestimation

Title Value Grade
P/S 32.55 1
P/BV 6.34 1
P/E 101.39 1
EV/EBITDA -3.98 0
Total: 3.5

Efficiency

Title Value Grade
ROA, % -36.17 0
ROE, % -185.71 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1312 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % 114.46 10
Yield Ebitda, % 48.51 6
Yield EPS, % 68.81 8
Total: 8
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
02.01.2025 02.01.2025 EcoR1 Capital, LLC
Director		 Purchase 12.95 86 066 6646 0 0.02 link
31.12.2024 02.01.2025 EcoR1 Capital, LLC
Director		 Purchase 12.93 171 555 13268 0 0.05 link
30.12.2024 02.01.2025 EcoR1 Capital, LLC
Director		 Purchase 12.92 842 177 65184 0 0.24 link
16.02.2024 21.02.2024 LOUMEAU ERIC J
CHIEF LEGAL OFFICER		 Sale 25 125 000 5000 0 -0.02 link
16.02.2024 21.02.2024 LOUMEAU ERIC J
CHIEF LEGAL OFFICER		 Purchase 14.02 70 100 5000 0 0.02 link
08.01.2024 09.01.2024 Faga Daniel
CEO		 Sale 21.81 149 747 6866 0 -0.02 link
06.01.2024 09.01.2024 Faga Daniel
CEO		 Purchase 23.04 411 264 17850 0 0.06 link

Institutions Volume Share, %
EcoR1 Capital, LLC 7521024 28.1
Deep Track Capital, LP 2036990 7.61
Tang Capital Management, LLC 1950609 7.29
Blackrock Inc. 1799823 6.73
Vanguard Group Inc 1380115 5.16
Boxer Capital, LLC 1300000 4.86
First Light Asset Management, LLC 1237178 4.62
Woodline Partners LP 1194974 4.47
Great Point Partners LLC 976981 3.65
Frazier Life Sciences Management, L.P. 899700 3.36

ETF Share, % Profitability for 1 year, % Dividends, %
Virtus LifeSci Biotech Clinical Trials ETF 1.25547 63.04 0.33
Goldman Sachs Future Health Care Equity ETF 0.33794 16.15 0.84646
iShares Micro-Cap ETF 0.19096 17.09 1.54048
Direxion Daily S&P Biotech Bull 3x Shares 0.15309 4067.92 0.25924
Future Tech ETF 0.11275 426.34 0.8416
Principal Healthcare Innovators ETF 0.11275 618.5 0.8416
Vanguard U.S. Momentum Factor ETF 0.11 30.05 1.05834
Invesco Nasdaq Biotechnology ETF 0.09827 28.58 0.8565
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.07304 18.2 1.66828
ProShares Ultra Nasdaq Biotechnology 0.06641 51.7 0.85651
Vanguard Russell 2000 Growth ETF 0.06 23.05 0.60264
Motley Fool Next Index ETF 0.05731 23.87 0.61129
iShares Russell 2000 Growth ETF 0.05618 38.04 0.6026
iShares ESG Aware MSCI USA Small-Cap ETF 0.05118 18.09 1.49366
Invesco BuyBack Achievers™ ETF 0.03524 20.81 1.59113
Vanguard Russell 2000 ETF 0.03 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.01996 17.47 1.51433
iShares Morningstar Small-Cap Growth ETF 0.01679 587.89 0.72598
iShares Morningstar Small-Cap Growth ETF 0.01679 33.63 0.72598
ProShares UltraPro Russell2000 0.01627 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.01155 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.01155 30.1 1.60498
Fidelity MSCI Health Care Index ETF 0.00789 3 1.46057
iShares Morningstar Small Cap Value ETF 0.00735 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.00735 201.65 2.50476
FlexShares Morningstar US Market Factor Tilt Index Fund 0.0053 21.94 1.69572
Avantis Responsible U.S. Equity ETF 0.00441 26.78 1.45257
ProShares Hedge Replication ETF 0.00439 5.92 1.47892
Humankind US Stock ETF 0.00382 18.81 1.99919
iShares Russell 3000 ETF 0.00189 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00123 24.86 1.43354
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Mr. Dennis M. Mulroy Chief Financial Officer 448.81k 1955 (70 years)
Mr. Eric J. Loumeau Chief Legal Officer 685.59k 1963 (62 years)
Ms. Beth Mueller Senior Vice President of Human Resources N/A
Dr. Martin Dahl Ph.D. Senior Vice President of Research N/A
Mr. Daniel R. Faga President, CEO & Director 867.12k 1980 (45 years)
Dr. Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D. Chief Medical Officer 656.36k 1975 (50 years)
Mr. Benjamin Stone Chief Business Officer N/A
Mr. Douglas A. Rich M.B.A. Senior Vice President of CMC N/A 1969 (56 years)
Ms. Monique Da Silva Senior Vice President of Corporate Affairs N/A
Ms. Priya Raina Senior Vice President of Clinical Operations

Address: United States, San Diego, CA , 10421 Pacific Center Court - open in Google maps, open in Yandex maps
Website: http://www.anaptysbio.com